[1]Bronster DJ, Emre S, Boccagni P, et al.Centralnervous systemcomplications in liver transplant recipients-incidence, timing, andlong-term follow-up[J].Clin Transplant, 2000, 14 (1) :1-7.
|
[2]Yu J, Liang TB, Zheng SS.The possible causes of central pontinemyelinolysis after liver transplantation[J].Zhonghua Waike Zazhi, 2004, 42 (17) :1048-1051.
|
[3]张舒凤, 崔莉莉, 闫四梅, 等.肝移植术后脑桥中央髓鞘溶解症5例[J].疑难病杂志, 2009, 8 (10) :587-590.
|
[4]Shintani M, Yamashita M, Nakano A, et al.Central pontine andextrapontine myelinolysis associated with type 2 diabetic patientwith hypokalemia[J].Diabetes Res Cli Pract, 2005, 68 (1) :75-80.
|
[5]Busuttil RW, Klintmalm GB.Transplantation of the liver[M].2nd ed, New York:Elsevier-Saunders, 2005:1031-1036.
|
[6]罗逸潜, 郭闻渊, 傅志仁.肝移植术后脱髓鞘疾病病因的研究进展[J].第二军医大学学报, 2010, 31 (1) :104-107.
|
[7]Kato T, Hattori H, Nagato M, et al.Subclinical central pontinemyelinolysis following liver transplantation[J].Brain Dev, 2002, 24 (3) :179-182.
|
[8]Kumar SK, Mone AP, Gray LC, et al.Central pontine myelinolysis:delayed chemqes on meuroinaging[J].Neuroimaging, 2000, 10 (3) :169-171.
|
[9]Thjodleifsson B, Beker JA, Dekkers C, et al.Rabeprazole versusomeprazole in preventing relapse of eresive or ulcerativegastroesophag eal reflux diseas:a double-blind, multicenter, European trial.The Eurapean Rabeprazole Study Group[J].DigDis Sci, 2000, 45 (5) :845-853.
|
[10]Deluca GC, Nagy Z, Esiri MM, et al.Evidence for a role forapoptosis in central pontine myelinolysis[J].Acta Neuropathol, 2002, 103 (6) :590-598.
|
[11]Zhang ZW, Kang Y, Deng LJ, et al.Therapy of central pontinemyelinolysis following living donor liver transplantation:Report ofthree cases[J].World J Gastroenterol, 2009, 15 (31) :3960-3963.
|
[12]Ludwig KP, Thiesset HF, Gayowski TJ, et al.Plasmapheresis andIntravenous Immune Globulin Improve Neurologic Outcome ofCentral Pontine Myelinolysis Occurring Post Orthotopic LiverTransplant[J].Ann Pharmacother, 2011, 45 (2) :10-15.
|
[1] | Afang SU, Xiaozhong JIANG, Yunshui ZHANG, Shouling WU, Guangjian LI. Influence of serum cumulative triglyceride exposure on the risk of acute pancreatitis[J]. Journal of Clinical Hepatology, 2024, 40(12): 2492-2498. doi: 10.12449/JCH241220 |
[2] | Rongjie LI, Yi PENG, Xiaolong TANG, Decai ZHANG, Shaojun LIU. Establishment of a modified BISAP scoring system and its clinical significance in the early diagnosis and prognostic evaluation of severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2023, 39(10): 2432-2442. doi: 10.3969/j.issn.1001-5256.2023.10.022 |
[3] | Minyue YIN, Jinzhou ZHU, Lu LIU, Jingwen GAO, Jiaxi LIN, Chunfang XU. Research advances in machine learning models for acute pancreatitis[J]. Journal of Clinical Hepatology, 2023, 39(12): 2978-2984. doi: 10.3969/j.issn.1001-5256.2023.12.034 |
[4] | Heming HUANG, Huiying YANG, Yingying QIN, Guodu TANG. Relationship between visceral fat related index and the severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(10): 2313-2319. doi: 10.3969/j.issn.1001-5256.2022.10.021 |
[5] | Wenqian XU, Min GUO, Xiao WANG, Yaoqi WU, Jinyuan ZHANG, Heguo LI. Molecular mechanism of liver injury in acute pancreatitis[J]. Journal of Clinical Hepatology, 2022, 38(11): 2663-2668. doi: 10.3969/j.issn.1001-5256.2022.11.045 |
[6] | Yongfeng YAN, Xin JIANG, Rui ZHONG, Huan XU, Yan PENG, Xiaowei TANG. Association of the duration of systemic inflammatory response syndrome with infectious pancreatic necrosis at the initial stage of acute pancreatitis[J]. Journal of Clinical Hepatology, 2021, 37(3): 654-659. doi: 10.3969/j.issn.1001-5256.2021.03.029 |
[7] | CAO Fei, PAN ChangBao, XU QingCheng, CHEN WeiWei, DENG DengHao, XIANG XiaoXing, CHEN Juan. Treatment of recurrent acute pancreatitis caused by incomplete pancreatic divisum via stent implantation of the accessory pancreatic duct by a reversed guide wire through the main pancreatic duct: A case report[J]. Journal of Clinical Hepatology, 2020, 36(12): 2805-2807. doi: 10.3969/j.issn.1001-5256.2020.12.033 |
[8] | Ma Min, Zhou ZhongYin. A comparative analysis of acute pancreatitis and hyperamylasemia after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2020, 36(2): 395-398. doi: 10.3969/j.issn.1001-5256.2020.02.033 |
[9] | LIU Hui, LI XianQiu, LUO Gang, TANG ShiXiao. Risk factors for new-onset diabetes after incipient acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2771-2776. doi: 10.3969/j.issn.1001-5256.2020.12.026 |
[10] | ZHANG Ting, LI Ting, HUANG YuMei, WANG 烜. Value of body fat parameters in predicting the severity of acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(12): 2761-2764. doi: 10.3969/j.issn.1001-5256.2020.12.024 |
[11] | Lyu NongHua, He WenHua. Endoscopic therapy for acute pancreatitis[J]. Journal of Clinical Hepatology, 2020, 36(8): 1688-1690. doi: 10.3969/j.issn.1001-5256.2020.08.002 |
[12] | Huang Lei, Zhao XianLin, Wang MingHao, Wang XiaoXiang. Role of adenosine monophosphate-activated protein kinase in acute pancreatitis[J]. Journal of Clinical Hepatology, 2019, 35(10): 2365-2368. doi: 10.3969/j.issn.1001-5256.2019.10.052 |
[13] | Ren LiNan, Guo XiaoZhong, Li HongYu, Zhao JianCheng. Clinical significance of C-reactive protein for assessment and outcomes of severe acute pancreatitis[J]. Journal of Clinical Hepatology, 2015, 31(5): 691-693. doi: 10.3969/j.issn.1001-5256.2015.05.014 |
[14] | Hou Fei, Liu RuiXia, Yin ChengHong. Pathogenetic mechanism of microcirculatory disturbance and treatment advances in acute pancreatitis[J]. Journal of Clinical Hepatology, 2014, 30(8): 815-818. doi: 10.3969/j.issn.1001-5256.2014.08.033 |
[15] | Pancreas Study Group, Chinese Society of Gastroenterology, Chinese Medical Association, Editorial Board of Chinese Journal of Pancreatology, Editorial Board of Chinese Journal of Digestion. Chinese guidelines for the management of acute pancreatitis ( Shanghai, 2013)[J]. Journal of Clinical Hepatology, 2013, 29(9): 656-660. doi: 10.3969/j.issn.1001-5256.2013.09.006 |
[16] | Liu ChengYi, Chen YanDong. Measurement of serum leptin level in acute pancreatitis patients[J]. Journal of Clinical Hepatology, 2009, 25(6): 437-439. |
[17] | Wang Zhong, Liu Yi, Min FuYuan, Liu HuiZhen. Detection and clinical significance of C3、Tf、α1-AT in serum of patients with hepatitis B.[J]. Journal of Clinical Hepatology, 2006, 22(2): 99-100. |
[20] | You Zhen, Zhang XueChun. The relationship of TNF-α、IL-6 in portal vein and hepatic damage in SAP rats[J]. Journal of Clinical Hepatology, 2004, 20(5): 295-296. |